Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders.
about
Deep Response in Multiple Myeloma: A Critical ReviewClass III Receptor Tyrosine Kinases in Acute Leukemia - Biological Functions and Modern Laboratory AnalysisMinimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologiesPrognostic significance and treatment implications of minimal residual disease studies in Philadelphia-negative adult acute lymphoblastic leukemiaNew criteria for response assessment: role of minimal residual disease in multiple myelomaNext-generation sequencing: advances and applications in cancer diagnosisMantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agentsAdvancing the Minimal Residual Disease Concept in Acute Myeloid LeukemiaDetection of Immunoglobulin Heavy Chain Gene Clonality by Next-Generation Sequencing for Minimal Residual Disease Monitoring in B-Lymphoblastic Leukemia.Next generation MRD.Comparative analysis of minimal residual disease detection by multiparameter flow cytometry and enhanced ASO RQ-PCR in multiple myelomaPost-Autologous (ASCT) Stem Cell Transplant Therapy in Multiple MyelomaGalectin-3 mediates bone marrow microenvironment-induced drug resistance in acute leukemia cells via Wnt/β-catenin signaling pathway.cFinder: definition and quantification of multiple haplotypes in a mixed sample.VDJtools: Unifying Post-analysis of T Cell Receptor Repertoires.A technical application of quantitative next generation sequencing for chimerism evaluationMinimal residual disease monitoring by 8-color flow cytometry in mantle cell lymphoma: an EU-MCL and LYSA study.A CD138-independent strategy to detect minimal residual disease and circulating tumour cells in multiple myeloma.Dynamic monitoring of circulating tumor DNA in non-Hodgkin lymphoma.Minimal Identifiable Disease and the Role of Conditioning Intensity in Hematopoietic Cell Transplantation for Myelodysplastic Syndrome and Acute Myelogenous Leukemia Evolving from Myelodysplastic SyndromeClonotypic Light Chain Peptides Identified for Monitoring Minimal Residual Disease in Multiple Myeloma without Bone Marrow Aspiration.Eye on the B-ALL: B-cell receptor repertoires reveal persistence of numerous B-lymphoblastic leukemia subclones from diagnosis to relapse.Minimal residual disease after transplantation or lenalidomide-based consolidation in myeloma patients: a prospective analysis.The prognostic value of clonal heterogeneity and quantitative assessment of plasma circulating clonal IG-VDJ sequences at diagnosis in patients with follicular lymphoma.Modern immunotherapy of adult B-lineage acute lymphoblastic leukemia with monoclonal antibodies and chimeric antigen receptor modified T cells.Allogeneic stem cell transplantation in multiple myeloma: immunotherapy and new drugs.Minimal Residual Disease Monitoring in Adult ALL to Determine Therapy.T-cell receptor profiling in cancer.Evolution of lymphoma staging and response evaluation: current limitations and future directions.High-throughput sequencing for noninvasive disease detection in hematologic malignancies.Utilizing next-generation sequencing in the management of multiple myeloma.Stem cell transplantation in multiple myeloma and other plasma cell disorders (report from an EBMT preceptorship meeting).High expression of CPNE3 predicts adverse prognosis in acute myeloid leukemia.Minimal Residual Disease in Acute Lymphoblastic Leukemia: How to Recognize and Treat It.Is Next-Generation Sequencing the way to go for Residual Disease Monitoring in Acute Lymphoblastic Leukemia?Multiple myeloma: disease response assessment.Circulating Tumor DNA to Monitor Therapy for Aggressive B-Cell Lymphomas.Detection of classical Hodgkin lymphoma specific sequence in peripheral blood using a next-generation sequencing approach.Next-Generation Sequencing in Adult B Cell Acute Lymphoblastic Leukemia Patients.Recommendations for Clinical Trial Development in Mantle Cell Lymphoma.
P2860
Q26771228-B4CC7F1A-0DBB-4FF5-B973-2E3C62FFBF4EQ26797245-01B9B38D-AB41-4012-A973-69E32951EB09Q26828511-1D6B040F-4D0C-4ED8-BF2F-F7929C207BB0Q27006773-E81356A4-E71F-4F45-9104-248B8BE81CEBQ27027512-0A3AED9C-B488-4194-9102-3D7780D225B8Q28073891-6C431951-A528-4CBE-8435-D4A529DFB4C4Q28075606-C4721AF4-7CBD-42F5-948F-DCE8682A9A7BQ28087291-1C91EF87-3DCD-436A-8D93-CFE25B0755F2Q33614375-7E390BD4-5810-484A-B189-1986D8089B6AQ34406955-6F0324CC-AD4E-481B-9123-34A8F5D4C3CFQ34454581-608EBEAA-4100-4ABF-8D44-3B92C4267812Q34694749-B9C68A9D-4045-4765-AB89-E6775BF0C12EQ35096615-7ED311AC-C2FB-4742-83F3-3BB43D538220Q35766176-9284C78B-AC44-4E1B-B223-66DC3C27FD01Q35852353-78DFE4BC-4821-4053-83F2-A288D64B8BE2Q36097066-A754487B-B427-4723-83DC-8406F6B6F9C2Q36750463-CA63DFD3-23BB-4321-B845-7D4670D8F677Q37032148-FA91D67B-38AE-4D18-BEFF-69C786088A7AQ37035820-54201ACA-E433-4417-940A-3DC7F094998AQ37207443-CEBCF3F1-4EE6-4506-A20E-550793C59D55Q37213155-D2695A84-AC52-4801-A1BC-60AC2CAED4CCQ37500642-56E325F7-52D5-4A69-996B-0BF2143FBDA6Q37701511-CA8F93E4-F0DA-44AD-A7AB-DDB13B08D26FQ37702797-3E8507C6-ABBF-4E19-A422-4479B136B92DQ38312596-91C81462-EEEF-44DA-ADB5-866488B263EDQ38417073-15BBF5F9-DFB4-4495-B831-B652AFBDE763Q38452047-5D2D3A1A-8420-464A-A942-B6A796D9D222Q38592595-2C9E6B80-9C66-475C-9A83-F7A4B5A81A21Q38671671-3759EBDD-2DD7-44D3-828C-F52266876C46Q38672646-56578320-8FEF-434F-B47F-77005415E57DQ38681814-6340CD19-9F33-4419-BE35-684878BC93C1Q38688055-8D46968E-762A-4B8F-AC45-E318F752D147Q38697273-98A738A5-5456-4D27-A48E-7DC5D4B41A72Q38756821-268FAD7D-1B3C-48BC-9330-ED51473DE610Q38815331-ED6F1943-C19B-457A-8B3A-C1C7D583E269Q38895092-C4644BFF-B605-481D-98A0-7590C7E43A5AQ38909384-94706F4B-E069-4505-AC8E-D49B5FA50F82Q39024241-9C554E7F-63CD-4824-8490-CBD2B899B40FQ39035188-14793FF7-1A15-4DA3-841C-FAA5BF5601EBQ39045701-76A01D9E-C994-4F1C-8F61-0EF767CB1A7E
P2860
Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Next-generation sequencing and ...... detection in B-cell disorders.
@en
Next-generation sequencing and ...... detection in B-cell disorders.
@nl
type
label
Next-generation sequencing and ...... detection in B-cell disorders.
@en
Next-generation sequencing and ...... detection in B-cell disorders.
@nl
prefLabel
Next-generation sequencing and ...... detection in B-cell disorders.
@en
Next-generation sequencing and ...... detection in B-cell disorders.
@nl
P2093
P2860
P50
P356
P1433
P1476
Next-generation sequencing and ...... detection in B-cell disorders
@en
P2093
H Trautmann
L Monitillo
M Boccadoro
M Brüggemann
P2860
P2888
P304
P356
10.1038/LEU.2013.375
P577
2013-12-17T00:00:00Z
P6179
1019353618